Cargando…

Which Nutritional Factors Are Good for HDL?

Detalles Bibliográficos
Autores principales:	Yanai, Hidekatsu, Tada, Norio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2018
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225857/ https://www.ncbi.nlm.nih.gov/pubmed/30425767 http://dx.doi.org/10.14740/jocmr3646

Ejemplares similares

Which Factor Determines the Duration Required for Relief of Glucotoxicity by the Intensive Insulin Therapy?
por: Yanai, Hidekatsu, et al.
Publicado: (2018)

Effects of Dietary Fat Intake on HDL Metabolism
por: Yanai, Hidekatsu, et al.
Publicado: (2015)

Understanding of Diabetic Dyslipidemia by Using the Anion-Exchange High Performance Liquid Chromatography Data
por: Yanai, Hidekatsu, et al.
Publicado: (2016)

Effects of Carbohydrate and Dietary Fiber Intake, Glycemic Index and Glycemic Load on HDL Metabolism in Asian Populations
por: Yanai, Hidekatsu, et al.
Publicado: (2014)

Bofutsushosan Significantly Ameliorated Betamethasone-Induced Cushing’s Syndrome
por: Yanai, Hidekatsu
Publicado: (2018)

Adiposity is the Crucial Enhancer of COVID-19
por: Yanai, Hidekatsu
Publicado: (2020)

A Significance of High Prevalence of Diabetes and Hypertension in Severe COVID-19 Patients
por: Yanai, Hidekatsu
Publicado: (2020)

Significant Correlations of SARS-CoV-2 Infection With Prevalence of Overweight/Obesity and Mean Body Mass Index in the SARS-CoV-2 Endemic Countries
por: Yanai, Hidekatsu
Publicado: (2020)

Acute Effects of Preventing Heart Failure by Sodium-Glucose Cotransporter 2 Inhibitors
por: Yanai, Hidekatsu
Publicado: (2021)

A simple hepatic cyst with elevated serum and cyst fluid CA19-9 levels: a case report
por: Yanai, Hidekatsu, et al.
Publicado: (2008)

A Different Effect of an Orexin Receptor Antagonist on Metabolic Parameters Between Diabetic Patients and Non-Diabetic Patients
por: Yanai, Hidekatsu, et al.
Publicado: (2018)

An Influence of the Estimated Glomerular Filtration Rate on Improvement in Metabolic Parameters by Sodium-Glucose Cotransporter 2 Inhibitors
por: Katsuyama, Hisayuki, et al.
Publicado: (2016)

A Possible Mechanism for Renoprotective Effect of Sodium-Glucose Cotransporter 2 Inhibitor: Elevation of Erythropoietin Production
por: Yanai, Hidekatsu, et al.
Publicado: (2017)

Does Metformin Assist New Anti-Diabetic Drugs to Succeed?
por: Kastuyama, Hisayuki, et al.
Publicado: (2019)

Habit of Bathing or Showering Is Beneficially Associated With Body Weight and Abdominal Circumference in Patients With Type 2 Diabetes
por: Katsuyama, Hisayuki, et al.
Publicado: (2018)

The Application of Sodium-Glucose Cotransporter 2 Inhibitors to Chronic Kidney Disease Stage 4
por: Koguchi, Ayako, et al.
Publicado: (2017)

Renoprotective Effect of Xanthine Oxidase Inhibitor, Topiroxostat
por: Katsuyama, Hisayuki, et al.
Publicado: (2019)

What Properties of Sodium-Glucose Cotransporter 2 Inhibitors Determine the Improvement in Hemoglobin A1c and Body Weight?
por: Yanai, Hidekatsu, et al.
Publicado: (2017)

The Possible Mechanisms for Improvement of Liver Function due to Sodium-Glucose Cotransporter-2 Inhibitors
por: Yanai, Hidekatsu, et al.
Publicado: (2019)

Clinical, radiological, and biochemical characteristics in patients with diseases mimicking polymyalgia rheumatica
por: Yanai, Hidekatsu, et al.
Publicado: (2009)

Quantifying the HDL proteome by mass spectrometry: how many proteins truly associate with HDL?
por: Marsche, Gunther
Publicado: (2018)

An Effective Insulin Therapy in Combination With Sodium-Glucose Cotransporter 2 Inhibitors
por: Yanai, Hidekatsu, et al.
Publicado: (2019)

A Possible Exquisite Crosstalk of Urate Transporter 1 With Other Urate Transporters for Chronic Kidney Disease and Cardiovascular Disease Induced by Dotinurad
por: Yanai, Hidekatsu, et al.
Publicado: (2023)

Nutrition for Sarcopenia
por: Yanai, Hidekatsu
Publicado: (2015)

Antihypertensive effects of astaxanthin
por: Yanai, Hidekatsu, et al.
Publicado: (2008)

Myositis, Vasculitis, Hepatic Dysfunction in Adult-Onset Still's Disease
por: Yanai, Hidekatsu, et al.
Publicado: (2009)

Reconsidering low HDL-cholesterol levels as a predictive factor for the development of hepatocellular carcinoma
por: Fujii, Hideki, et al.
Publicado: (2023)

Streptococcal Infection Can Be the Trigger for Thyroid Storm
por: Hakoshima, Mariko, et al.
Publicado: (2019)

Letter regarding “Associations of non-HDL-C and triglyceride/HDL-C ratio with coronary plaque burden and plaque characteristics in young adults”
por: Aktas, Gulali
Publicado: (2023)

Reply to: “Reconsidering low HDL-cholesterol levels as a predictive factor for the development of hepatocellular carcinoma”
por: Crudele, Lucilla, et al.
Publicado: (2023)

Goodness-of-Fit of the Fractal Dimension as a Prognostic Factor
por: Metze, Konradin, et al.
Publicado: (2009)

Stroke rehabilitation: Which factors influence the outcome?
por: Dušica, Simić-Panić S, et al.
Publicado: (2015)

Diacylglycerol oil for the metabolic syndrome
por: Yanai, Hidekatsu, et al.
Publicado: (2007)

The underlying mechanisms for development of hypertension in the metabolic syndrome
por: Yanai, Hidekatsu, et al.
Publicado: (2008)

A molecular mechanism for diacylglycerol-mediated promotion of negative caloric balance
por: Yanai, Hidekatsu, et al.
Publicado: (2009)

The anti-inflammatory function of follicular fluid HDL and outcome of modified natural cycle in vitro fertilization(†)
por: Jia, Congzhuo, et al.
Publicado: (2020)

Good news for Kerala
por: Gupta, Prabha Nini, et al.
Publicado: (2016)

Texture and color enhancement imaging for detecting colorectal adenomas: Good, but not good enough
por: Wang, Ying, et al.
Publicado: (2022)

Good Cholesterol Gone Bad? HDL and COVID-19
por: Kluck, George E. G., et al.
Publicado: (2021)

RESEARCH IN INDIA: NOT GOOD ENOUGH?
por: Patel, Vikram
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_66b8ovsg2pginb2dkmpdk5e1pf